Inflammatorisk tarmsjukdom och translationell gastroenterologi
Om gruppen
Gruppuppgifter
Kontaktperson
Forskningsämne
Forskningsmiljöer
Our research aims to improve the quality of life of patients with inflammatory bowel disease (IBD, including microscopic colitis, and also of patients with other gastrointestinal diseases. Exploring the molecular profile of these diseases is an integral part of projects performed in our research group. The overarching aim of our research is to identify markers for improved clinical decision making and to uncover pathophysiological mechanisms behind these markers or signatures of markers. Epidemiological and mechanistic links between various disease elements and across different phases of the diseases are examined. Our research programs are conducted in collaboration with national and international research groups, patient organisations, and private companies within the biomarker-, pharmaceutical- and digital sector.
/Jonas Halfvarson, MD, PhD
Professor of Gastroenterology and Consultant Gastroenterologist
Forskare
- Daniel Bergemalm
- Johan Bohr
- Carl Eriksson
- Jonas Halfvarson
- Robert Kruse
- Mårten Lindqvist
- Nils Nyhlin
- Ignacio Rangel
- Ida Schoultz
- Michiel van Nieuwenhoven
- Yaroslava Zhulina
- Ahmed Al-Ahmadi, Doktorand
- Erik Andersson, Doktorand
- Manar Bitar, Doktorand
- Olle Björkqvist, Doktorand
- Sara Karlqvist, Doktorand
- Lucian Marinica Grando, Doktorand
- Jussi Rauma, Doktorand
- Benita Salomon, Doktorand
- Qays Shahed, Doktorand
- Sarita Shrestha, Doktorand
- Joel Thunberg, Doktorand
- Isabella Visuri, Doktorand
Forskningsprojekt
Pågående projekt
- 3TR
- Bedömning av anorektal funktion hos patienter med inflammatorisk tarmsjukdom.
- BIO IBD - A multi-modal national study to identify BIOmarkers for diagnosis, therapy response and disease progression in IBD
- Effekterna av en lågenergidiet jämfört med lågenergidiet och intragastrisk ballong hos vuxna med fetma, allt i kombination med gruppbehandling: en randomiserad, kontrollerad, 1-årig studie.
- Epidemiology and Genetic epidemiology
- Genome, genome regulation and expression
- Intestinal macrophages in pathogenesis of inflammatory bowel disease
- Irritable bowel syndrome in primary health care
- NORDTREAT
- Phenotyping and treatment of primary health care IBS patients
- Psychological and physiological factors predicting tolerability and weight loss of intragastric balloon in combination with low energy diet and group treatment in adults with obesity
